What is the current annual cash & cash equivalents of ABT?

As of today, ABT annual cash & cash equivalents is $8.94B

What is 1-year change in ABT annual cash & cash equivalents?

ABT annual cash & cash equivalents is up +12.20% year-over-year

What is 3-year change in ABT annual cash & cash equivalents?

ABT annual cash & cash equivalents is down -12.10% over the past 3 years

How far is ABT annual cash & cash equivalents from its all-time high?

ABT annual cash & cash equivalents is currently -52.39% below its historical high of $18.78B set on December 31, 2016

How does ABT annual cash & cash equivalents rank versus sector peers?

ABT annual cash & cash equivalents is higher than 98.68% of companies in Healthcare sector

When is ABT next annual earnings release?

As of today, the next annual earnings release for ABT has not been scheduled

What is the current quarterly cash & cash equivalents of ABT?

As of today, ABT quarterly cash & cash equivalents is $5.60B

What is ABT quarterly cash & cash equivalents most recent change?

ABT quarterly cash & cash equivalents was down -23.19% on June 30, 2026

What is 1-year change in ABT quarterly cash & cash equivalents?

ABT quarterly cash & cash equivalents is down -23.06% year-over-year

How far is ABT quarterly cash & cash equivalents from its all-time high?

ABT quarterly cash & cash equivalents is currently -70.16% below its historical high of $18.78B set on December 31, 2016

How does ABT quarterly cash & cash equivalents rank versus sector peers?

ABT quarterly cash & cash equivalents is higher than 98.30% of companies in Healthcare sector

When is ABT next earnings release?

The next earnings release for ABT is on October 14, 2026

ABT Cash & Equivalents History & Chart Since 1981

Annual Cash & Cash Equivalents

$8.94B$972.00M+12.20%

December 31, 2025

Summary

Current Value: As of today, ABT annual cash & cash equivalents is $8.94B, up +12.20% on December 31, 2025
Historical Performance: ABT annual cash & cash equivalents is down -12.10% over the past 3 years, up +25.06% over the past 5 years
All-Time High Comparison: ABT annual cash & cash equivalents is currently -52.39% below its historical high of $18.78B set on December 31, 2016
3-Year Low Comparison: ABT annual cash & cash equivalents is +22.81% above its 3-year low of $7.28B reached on December 31, 2023
Sector Comparison: ABT annual cash & cash equivalents is higher than 98.68% of companies in Healthcare sector

Cash and Cash Equivalents Chart

beforeafter

SUGGESTED SERIES

Performance

ABT Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual Cash & Cash Equivalents	Dec 31, 25	$8.94B	+12.2%	-12.1%	+25.1%	+22.1%
Quarterly Cash & Cash Equivalents	Jun 30, 26	$5.60B	-23.1%	-31.3%	-37.4%	-37.0%
Price	Aug 13, 26	$111.27	-13.9%	+4.9%	-9.6%	+367.3%
Annual Current Assets	Dec 31, 25	$26.00B	+9.9%	+3.1%	+27.2%	+16.5%
Annual Total Liabilities	Dec 31, 25	$33.94B	+1.3%	-9.6%	-14.2%	-10.2%
Annual Working Capital	Dec 31, 25	$9.50B	+0.0%	-2.4%	+11.3%	+87.9%
Annual Net Income	Dec 31, 25	$6.50B	-51.3%	-5.9%	+46.1%	+40.9%

Cash and Cash Equivalents Highs

ABT Annual Cash & Cash Equivalents Highs Comparison
Period	High	Date	Current
3Y	$10.17B	N/A	-12.1%
5Y	$10.25B	Dec 31, 21	-12.8%
All	$18.78B	Dec 31, 16	-52.4%

Cash and Cash Equivalents Lows

ABT Annual Cash & Cash Equivalents Lows Comparison
Period	Low	Date	Current
3Y	$7.28B	Dec 31, 23	+22.8%
5Y	$7.15B	N/A	+25.1%
All	$48.67M	Dec 31, 89	>+9999.0%

Cash and Cash Equivalents History

Year	Value	Change
2025	$8.94B	+12.2%
2024	$7.97B	+9.5%
2023	$7.28B	-28.4%
2022	$10.17B	-0.8%
2021	$10.25B	+43.4%
2020	$7.15B	+72.7%
2019	$4.14B	+1.3%
2018	$4.09B	-57.5%
2017	$9.61B	-48.8%
2016	$18.78B	+206.5%
2015	$6.13B	+37.3%
2014	$4.46B	-44.9%
2013	$8.10B	-46.6%
2012	$15.17B	+87.4%
2011	$8.10B	+10.6%
2010	$7.32B	-26.3%
2009	$9.93B	+95.5%
2008	$5.08B	+80.1%
2007	$2.82B	+105.4%
2006	$1.37B	-53.5%

Year	Value	Change
2005	$2.96B	+43.6%
2004	$2.06B	+60.1%
2003	$1.29B	+33.2%
2002	$966.13M	+35.4%
2001	$713.54M	-38.3%
2000	$1.16B	+59.9%
1999	$723.30M	+88.7%
1998	$383.32M	+48.0%
1997	$259.01M	+110.4%
1996	$123.08M	-61.0%
1995	$315.70M	+0.1%
1994	$315.33M	-16.8%
1993	$378.83M	+46.7%
1992	$258.18M	+76.6%
1991	$146.23M	+175.1%
1990	$53.15M	+9.2%
1989	$48.67M	-91.6%
1988	$582.65M	+12.1%
1987	$519.93M	+300.9%
1981	$129.68M	-

FAQ

What is the current annual cash & cash equivalents of ABT?: As of today, ABT annual cash & cash equivalents is $8.94B
What is 1-year change in ABT annual cash & cash equivalents?: ABT annual cash & cash equivalents is up +12.20% year-over-year
What is 3-year change in ABT annual cash & cash equivalents?: ABT annual cash & cash equivalents is down -12.10% over the past 3 years
How far is ABT annual cash & cash equivalents from its all-time high?: ABT annual cash & cash equivalents is currently -52.39% below its historical high of $18.78B set on December 31, 2016
How does ABT annual cash & cash equivalents rank versus sector peers?: ABT annual cash & cash equivalents is higher than 98.68% of companies in Healthcare sector
When is ABT next annual earnings release?: As of today, the next annual earnings release for ABT has not been scheduled

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Quarterly Cash & Cash Equivalents

$5.60B$1.69B-23.19%

June 30, 2026

Summary

Current Value: As of today, ABT quarterly cash & cash equivalents is $5.60B, down -23.19% on June 30, 2026
Historical Performance: ABT quarterly cash & cash equivalents is down -23.06% year-over-year, down -31.29% over the past 3 years
All-Time High Comparison: ABT quarterly cash & cash equivalents is currently -70.16% below its historical high of $18.78B set on December 31, 2016
3-Year Low Comparison: ABT quarterly cash & cash equivalents is at its 3-year low
Sector Comparison: ABT quarterly cash & cash equivalents is higher than 98.30% of companies in Healthcare sector

Performance

ABT Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly Cash & Cash Equivalents	Jun 30, 26	$5.60B	-23.2%	-23.1%	-31.3%	-37.4%
Annual Cash & Cash Equivalents	Dec 31, 25	$8.94B	–	+12.2%	-12.1%	+25.1%
Price	Aug 13, 26	$111.27	+31.1%	-13.9%	+4.9%	-9.6%
Quarterly Current Assets	Jun 30, 26	$24.52B	-3.9%	+0.2%	+4.3%	+8.3%
Quarterly Total Liabilities	Jun 30, 26	$57.45B	-0.5%	+73.2%	+59.8%	+46.4%
Quarterly Working Capital	Jun 30, 26	$6.70B	-6.0%	-39.2%	-26.8%	-33.1%
Quarterly Net Income	Jun 30, 26	$928.00M	-13.8%	-48.4%	-32.3%	-21.6%

Quarterly Cash & Cash Equivalents Highs

ABT Quarterly Cash & Cash Equivalents Highs Comparison
Period	High	Date	Current
1Y	$8.94B	Dec 31, 25	-37.3%
3Y	$8.94B	Dec 31, 25	-37.3%
5Y	$10.25B	Dec 31, 21	-45.3%
All	$18.78B	Dec 31, 16	-70.2%

Quarterly Cash & Cash Equivalents Lows

ABT Quarterly Cash & Cash Equivalents Lows Comparison
Period	Low	Date	Current
1Y	$5.60B	Jun 30, 26	at low
3Y	$5.60B	Jun 30, 26	at low
5Y	$5.60B	Jun 30, 26	at low
All	$13.60M	Dec 31, 89	>+9999.0%

Quarterly Cash & Cash Equivalents History

Month	Value	Change
Jun 2026	$5.60B	-23.2%
Mar 2026	$7.30B	-18.4%
Dec 2025	$8.94B	+15.6%
Sep 2025	$7.73B	+6.2%
Jun 2025	$7.28B	+6.4%
Mar 2025	$6.84B	-14.1%
Dec 2024	$7.97B	+2.3%
Sep 2024	$7.79B	+7.9%
Jun 2024	$7.22B	+8.5%
Mar 2024	$6.65B	-8.6%
Dec 2023	$7.28B	+3.3%
Sep 2023	$7.05B	-13.6%
Jun 2023	$8.16B	-14.4%
Mar 2023	$9.53B	-6.3%
Dec 2022	$10.17B	+2.7%
Sep 2022	$9.91B	+6.6%
Jun 2022	$9.29B	+13.9%
Mar 2022	$8.16B	-20.4%
Dec 2021	$10.25B	+5.7%
Sep 2021	$9.69B	+8.4%
Jun 2021	$8.94B	+6.8%
Mar 2021	$8.37B	+17.1%
Dec 2020	$7.15B	+51.1%
Sep 2020	$4.73B	-6.1%
Jun 2020	$5.04B	+37.3%
Mar 2020	$3.67B	-11.4%
Dec 2019	$4.14B	-4.5%
Sep 2019	$4.34B	+28.4%
Jun 2019	$3.38B	+3.5%
Mar 2019	$3.26B	-20.2%
Dec 2018	$4.09B	-45.9%
Sep 2018	$7.55B	+131.3%
Jun 2018	$3.26B	-19.2%
Mar 2018	$4.04B	-57.9%
Dec 2017	$9.61B	-14.2%
Sep 2017	$11.20B	+13.9%
Jun 2017	$9.84B	+11.0%
Mar 2017	$8.86B	-52.8%
Dec 2016	$18.78B	+316.6%
Sep 2016	$4.51B	+1.6%
Jun 2016	$4.44B	+12.2%
Mar 2016	$3.96B	-35.4%
Dec 2015	$6.13B	-0.2%
Sep 2015	$6.14B	-45.1%
Jun 2015	$11.18B	+13.5%
Mar 2015	$9.85B	+120.8%
Dec 2014	$4.46B	-8.6%
Sep 2014	$4.88B	-30.9%
Jun 2014	$7.06B	+0.2%
Mar 2014	$7.05B	-13.0%
Dec 2013	$8.10B	-5.9%
Sep 2013	$8.61B	-8.4%
Jun 2013	$9.39B	+10.3%
Mar 2013	$8.52B	-43.9%
Dec 2012	$15.17B	+31.9%
Sep 2012	$11.50B	+4.6%
Jun 2012	$11.00B	+15.5%
Mar 2012	$9.53B	+17.7%
Dec 2011	$8.10B	+1.5%
Sep 2011	$7.98B	-10.3%
Jun 2011	$8.89B	+6.2%
Mar 2011	$8.38B	+14.4%
Dec 2010	$7.32B	+28.0%
Sep 2010	$5.72B	-8.4%
Jun 2010	$6.24B	+69.1%
Mar 2010	$3.69B	-62.8%
Dec 2009	$9.93B	+14.2%
Sep 2009	$8.70B	+26.2%
Jun 2009	$6.89B	+20.8%
Mar 2009	$5.70B	+12.3%

Month	Value	Change
Dec 2008	$5.08B	+34.9%
Sep 2008	$3.77B	-27.3%
Jun 2008	$5.18B	+42.4%
Mar 2008	$3.64B	+28.9%
Dec 2007	$2.82B	+10.7%
Sep 2007	$2.55B	+13.9%
Jun 2007	$2.24B	+36.3%
Mar 2007	$1.64B	+19.5%
Dec 2006	$1.37B	+30.7%
Sep 2006	$1.05B	-4.2%
Jun 2006	$1.10B	-54.4%
Mar 2006	$2.40B	-18.7%
Dec 2005	$2.96B	+1.0%
Sep 2005	$2.93B	+90.8%
Jun 2005	$1.53B	-15.4%
Mar 2005	$1.81B	-11.9%
Dec 2004	$2.06B	+60.1%
Dec 2003	$1.29B	+33.2%
Dec 2002	$966.13M	+35.4%
Dec 2001	$713.54M	-38.3%
Dec 2000	$1.16B	+19.5%
Sep 2000	$967.64M	-1.7%
Jun 2000	$984.25M	+26.9%
Mar 2000	$775.35M	+7.2%
Dec 1999	$723.30M	+14.7%
Sep 1999	$630.38M	+56.9%
Jun 1999	$401.75M	+1.2%
Mar 1999	$396.81M	+3.5%
Dec 1998	$383.32M	+39.9%
Sep 1998	$274.03M	-15.2%
Jun 1998	$323.01M	+9.5%
Mar 1998	$294.95M	+13.9%
Dec 1997	$259.01M	+56.4%
Sep 1997	$165.58M	+14.0%
Jun 1997	$145.19M	-4.6%
Mar 1997	$152.23M	+23.7%
Dec 1996	$123.08M	-31.3%
Sep 1996	$179.17M	+0.8%
Jun 1996	$177.67M	+34.6%
Mar 1996	$131.96M	-58.2%
Dec 1995	$315.70M	-23.9%
Sep 1995	$414.67M	+33.4%
Jun 1995	$310.86M	+24.3%
Mar 1995	$250.05M	-20.7%
Dec 1994	$315.33M	-1.1%
Sep 1994	$318.69M	+27.9%
Jun 1994	$249.07M	+20.0%
Mar 1994	$207.61M	-31.0%
Dec 1993	$300.68M	+118.2%
Sep 1993	$137.80M	+367.1%
Jun 1993	$29.50M	-42.7%
Mar 1993	$51.50M	-55.8%
Dec 1992	$116.60M	+328.7%
Sep 1992	$27.20M	-29.2%
Jun 1992	$38.40M	+70.7%
Mar 1992	$22.50M	-62.7%
Dec 1991	$60.40M	+22.0%
Sep 1991	$49.50M	-14.2%
Jun 1991	$57.70M	+6.3%
Mar 1991	$54.30M	+59.7%
Dec 1990	$34.00M	-71.1%
Sep 1990	$117.50M	+225.5%
Jun 1990	$36.10M	-52.9%
Mar 1990	$76.60M	+463.2%
Dec 1989	$13.60M	-97.7%
Dec 1988	$582.60M	+12.1%
Dec 1987	$519.90M	+8.0%
Dec 1986	$481.60M	+10.1%
Dec 1985	$437.50M	-2.1%
Dec 1984	$447.10M	-

FAQ

What is the current quarterly cash & cash equivalents of ABT?: As of today, ABT quarterly cash & cash equivalents is $5.60B
What is ABT quarterly cash & cash equivalents most recent change?: ABT quarterly cash & cash equivalents was down -23.19% on June 30, 2026
What is 1-year change in ABT quarterly cash & cash equivalents?: ABT quarterly cash & cash equivalents is down -23.06% year-over-year
How far is ABT quarterly cash & cash equivalents from its all-time high?: ABT quarterly cash & cash equivalents is currently -70.16% below its historical high of $18.78B set on December 31, 2016
How does ABT quarterly cash & cash equivalents rank versus sector peers?: ABT quarterly cash & cash equivalents is higher than 98.30% of companies in Healthcare sector
When is ABT next earnings release?: The next earnings release for ABT is on October 14, 2026

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

ABT Official Website www.abbott.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm
ABT Profile on Yahoo Finance finance.yahoo.com/quote/ABT
ABT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abt